MedCity News’s one-day INVEST Digital Health conference took place in Dallas on Wednesday, concluding with an exciting startup contest, this year, featuring six pediatric mental health startups.

As a physician, researcher, and biotech leader with personal experience of prostate cancer in my family, I’ve long advocated for putting patients first in our quest for medical innovation.

Most rural hospitals simply don’t have the resources to adopt AI at the same rate as other hospitals, so they oftentimes have to wait to deploy the tools that other hospitals are benefiting from ...

In a pair of letters, 195 members of Congress recently urged leadership to extend the enhanced premium tax credits that will expire in 2025. The enhanced premium tax credits — which were ...

A Zevra Therapeutics drug is now the first FDA-approved therapy for an ultra-rare, inherited metabolic disorder whose effects on the central nervous system can become fatal by the time a patient ...

Since ChatGPT burst onto the scene, hospital leaders have raced to figure out the best use cases for generative and non-generative AI technology. Many are already experimenting with AI in narrow ...

From left to right: Theresa Lanowitz, Chief Cybersecurity Evangelist at LevelBlue; Andrew Molosky, President and Chief Executive Officer at Chapters Health System and CareNu; Ben Schwering, Chief ...

From left to right: Shubhra Jain, Principal, Tarsadia Investments; Salvatore Viscomi, Chief Executive Officer and Co-Founder, Carna Health; David Stein, CEO, Ash Wellness; Pranitha Patil, Co ...

In an era of rising costs for everything from groceries to gasoline to healthcare, independent physicians are now going to receive less — not more — for taking care of our most-vulnerable ...

The struggle to determine the future of 23andMe has taken a turn with all of its independent directors resigning over differences with co-founder and CEO Anne Wojcicki, who wants to maintain ...

Visionary entrepreneurs like Henry Ford, Steve Jobs and Elon Musk have revolutionized industries, motivated not just by profit, but by a desire to improve people’s lives. Now, it’s healthcare ...

For years, I’ve watched promising medical technologies languish in labs, never reaching the patients who desperately need them. The culprit? Not overzealous regulators, but our antiquated ...